Hasil Pencarian - Sergey Shcherbinin

  • Menampilkan 1 - 13 hasil dari 13
Perbaiki Hasil
  1. 1
    Functional and genomic analyses of alpha-solenoid proteins.

    Functional and genomic analyses of alpha-solenoid proteins. oleh David Fournier, Gareth A Palidwor, Sergey Shcherbinin, Angelika Szengel, Martin H Schaefer, Carol Perez-Iratxeta, Miguel A Andrade-Navarro

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Preclinical PET Imaging and Toxicity Study of a <sup>68</sup>Ga-Functionalized Polymeric Cardiac Blood Pool Agent

    Preclinical PET Imaging and Toxicity Study of a <sup>68</sup>Ga-Functionalized Polymeric Cardiac Blood Pool Agent oleh Katayoun Saatchi, François Bénard, Navjit Hundal, Joshua Grimes, Sergey Shcherbinin, Maral Pourghiasian, Donald E. Brooks, Anna Celler, Urs O. Häfeli

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Donanemab (LY3002813) dose‐escalation study in Alzheimer's disease

    Donanemab (LY3002813) dose‐escalation study in Alzheimer's disease oleh Stephen Loucian Lowe, Brian A. Willis, Anne Hawdon, Fanni Natanegara, Laiyi Chua, Joanne Foster, Sergey Shcherbinin, Paul Ardayfio, John R. Sims

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Donanemab exposure and efficacy relationship using modeling in Alzheimer's disease

    Donanemab exposure and efficacy relationship using modeling in Alzheimer's disease oleh Ivelina Gueorguieva, Brian A. Willis, Laiyi Chua, Kay Chow, C. Steven Ernest II, Jian Wang, Sergey Shcherbinin, John R. Sims, Emmanuel Chigutsa

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Magnetic resonance imaging measures of brain volumes across the EXPEDITION trials in mild and moderate Alzheimer's disease dementia

    Magnetic resonance imaging measures of brain volumes across the EXPEDITION trials in mild and moderate Alzheimer's disease dementia oleh Diana Otero Svaldi, Ixavier A. Higgins, Karen C. Holdridge, Roy Yaari, Michael Case, Luc Bracoud, David Scott, Sergey Shcherbinin, John R. Sims

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Detection of alpha-rod protein repeats using a neural network and application to huntingtin.

    Detection of alpha-rod protein repeats using a neural network and application to huntingtin. oleh Gareth A Palidwor, Sergey Shcherbinin, Matthew R Huska, Tamas Rasko, Ulrich Stelzl, Anup Arumughan, Raphaele Foulle, Pablo Porras, Luis Sanchez-Pulido, Erich E Wanker, Miguel A Andrade-Navarro

    Diterbitkan 2009-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Tau as a diagnostic instrument in clinical trials to predict amyloid in Alzheimer's disease

    Tau as a diagnostic instrument in clinical trials to predict amyloid in Alzheimer's disease oleh Sergey Shcherbinin, Amanda Morris, Ixavier A. Higgins, Ilke Tunali, Ming Lu, Carmen Deveau, Sudeepti Southekal, Vikas Kotari, Cynthia D. Evans, Anupa K. Arora, Emily C. Collins, Michael Pontecorvo, Mark A. Mintun, John R. Sims

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Topographic staging of tau positron emission tomography images

    Topographic staging of tau positron emission tomography images oleh Adam J. Schwarz, Sergey Shcherbinin, Lawrence J. Slieker, Shannon L. Risacher, Arnaud Charil, Michael C. Irizarry, Adam S. Fleisher, Sudeepti Southekal, Abhinay D. Joshi, Michael D. Devous Sr., Bradley B. Miller, Andrew J. Saykin, Alzheimer's Disease Neuroimaging Initiative

    Diterbitkan 2018-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease

    Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease oleh Jennifer A. Zimmer, Sergey Shcherbinin, Michael D. Devous Sr., Sonja M. Bragg, Katherine J. Selzler, Alette M. Wessels, Craig Shering, Jamie Mullen, John Landry, Scott W. Andersen, AnnCatherine M. Downing, Adam S. Fleisher, Diana Otero Svaldi, John R. Sims

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease

    Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease oleh Shorena Janelidze, Erik Stomrud, Ruben Smith, Sebastian Palmqvist, Niklas Mattsson, David C. Airey, Nicholas K. Proctor, Xiyun Chai, Sergey Shcherbinin, John R. Sims, Gallen Triana-Baltzer, Clara Theunis, Randy Slemmon, Marc Mercken, Hartmuth Kolb, Jeffrey L. Dage, Oskar Hansson

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    PET quantification of brain O-GlcNAcase with [18F]LSN3316612 in healthy human volunteers

    PET quantification of brain O-GlcNAcase with [18F]LSN3316612 in healthy human volunteers oleh Jae-Hoon Lee, Jeih-San Liow, Soumen Paul, Cheryl L. Morse, Mohammad B. Haskali, Lester Manly, Sergey Shcherbinin, J. Craig Ruble, Nancy Kant, Emily C. Collins, Hugh N. Nuthall, Paolo Zanotti-Fregonara, Sami S. Zoghbi, Victor W. Pike, Robert B. Innis

    Diterbitkan 2020-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer’s disease

    Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer’s disease oleh Davina Biel, Ying Luan, Matthias Brendel, Paul Hager, Anna Dewenter, Alexis Moscoso, Diana Otero Svaldi, Ixavier A. Higgins, Michael Pontecorvo, Sebastian Römer, Anna Steward, Anna Rubinski, Lukai Zheng, Michael Schöll, Sergey Shcherbinin, Michael Ewers, Nicolai Franzmeier, the Alzheimer’s Disease Neuroimaging Initiative

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET

    CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET oleh Kwangsik Nho, Shannon L. Risacher, Liana G. Apostolova, Paula J. Bice, Jared R. Brosch, Rachael Deardorff, Kelley Faber, Martin R. Farlow, Tatiana Foroud, Sujuan Gao, Thea Rosewood, Jun Pyo Kim, Kelly Nudelman, Meichen Yu, Paul Aisen, Reisa Sperling, Basavaraj Hooli, Sergey Shcherbinin, Diana Svaldi, Clifford R. Jack, William J. Jagust, Susan Landau, Aparna Vasanthakumar, Jeffrey F. Waring, Vincent Doré, Simon M. Laws, Colin L. Masters, Tenielle Porter, Christopher C. Rowe, Victor L. Villemagne, Logan Dumitrescu, Timothy J. Hohman, Julia B. Libby, Elizabeth Mormino, Rachel F. Buckley, Keith Johnson, Hyun-Sik Yang, Ronald C. Petersen, Vijay K. Ramanan, Nilüfer Ertekin-Taner, Prashanthi Vemuri, Ann D. Cohen, Kang-Hsien Fan, M. Ilyas Kamboh, Oscar L. Lopez, David A. Bennett, Muhammad Ali, Tammie Benzinger, Carlos Cruchaga, Diana Hobbs, Philip L. De Jager, Masashi Fujita, Vaishnavi Jadhav, Bruce T. Lamb, Andy P. Tsai, Isabel Castanho, Jonathan Mill, Michael W. Weiner, for the Alzheimer’s Disease Neuroimaging Initiative (ADNI), the Department of Defense Alzheimer’s Disease Neuroimaging Initiative (DoD-ADNI), the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Study (A4 Study) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN), the Australian Imaging, Biomarker & Lifestyle Study (AIBL), Andrew J. Saykin

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: